Yüklüyor......
Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway
The mortality rate of non-small-cell lung cancer (NSCLC) remains high worldwide. Although cisplatin-based chemotherapy may greatly enhance patient prognosis, chemotherapy resistance remains an obstacle to curing patients with NSCLC. Therefore, overcoming drug resistance is the main route to successf...
Kaydedildi:
| Yayımlandı: | Front Cell Dev Biol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7892899/ https://ncbi.nlm.nih.gov/pubmed/33614623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2020.610097 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|